FI854171L - 1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL. - Google Patents

1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL.

Info

Publication number
FI854171L
FI854171L FI854171A FI854171A FI854171L FI 854171 L FI854171 L FI 854171L FI 854171 A FI854171 A FI 854171A FI 854171 A FI854171 A FI 854171A FI 854171 L FI854171 L FI 854171L
Authority
FI
Finland
Prior art keywords
phenyl
group
alkyl
atoms
radical
Prior art date
Application number
FI854171A
Other languages
Finnish (fi)
Other versions
FI854171A0 (en
Inventor
David Triggle
Eckhard Schwenner
Guenther Kinast
Stanislav Kazda
Andreas Knorr
Bernward Garthoff
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI854171A0 publication Critical patent/FI854171A0/en
Publication of FI854171L publication Critical patent/FI854171L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1. Compounds of the general formula (I) see diagramm : EP0179386,P26,F3 in which R represents phenyl, pyridyl or the benzoxadiazolyl radical, the phenyl radical containing 1 or 2 identical or different substituents from the group comprising nitro, trifluoromethyl, fluorine, chlorine and cyano, R**1 and R**3 are identical of different and each represent alkyl with 1 to 4 carbon atoms, or one of the substituents R**1 or R**3 represents hydroxymethyl, amino or cyano, R**2 represents hydrogen or alkyl with 1 or 2 carbon atoms, A either represents an alkylene group which has up to 12 carbon atoms and is substituted by methyl, ethyl or propyl, and which is optionally substituted or interrupted by a phenyl group and/or is optionally interrupted by an oxygen or sulphur atom or a grouping of the formula -NR**6 , or A represents a straight-chain or branched alkylene group which has up to 12 carbon atoms and is optionally interrupted by an oxygen or sulphur atom or a grouping of the formula -NR**6 when a) R**4 represents phenyl, benzyl, CO-R**6 , CO2 -R**6' , CO-NR**6 R**7 , SO2 R6 or -CH2 -CHOH-CH2 -OR**8 , or b) R represents pyridyl or benzoxadiazolyl, or c) R**5 represents indolyl, or d) the alkylene chain is interrupted by a sulphur atom or the group -NR**6 or e) X represents COR**9 , wherein R**6 und R**7 are identical or different and each represent hydrogen, alkyl with up to 4 C atoms, benzyl or phenyl and wherein R**8 has the meaning given for R**5 and can be identical or different from this radical wherein R**9 represents alkyl which has 1 to 7 C atoms and is optionally substituted by halogen, cyano, alkoxy or dialkylamino with in each case 1-4 C atoms, or denotes phenyl, naphthyl, phenylalkyl or anilino or an amino, monoalkylamino or dialkylamino group with in each case 1 to 4 C atoms, the alkyl groups optionally forming, with the nitrogen atom a 5-membered to 7-membered ring which can contain an oxygen atom as a further hetero-atom and wherein R**6' has the meaning of R**6 , but does not denote hydrogen, R**4 represents hydrogen, or represents straight-chain or branched alkyl with 1 to 3 carbon atoms, or represents phenyl or benzyl, or represents a radical of the formula CO-R**6 , CO2 -R**6' , CO-NR**6 R**7 , SO2 -R**6 or -CH2 -CHOH-CH2 -OR**8 , wherein R**6 , R**6' , R**7 , R**8 und R**9 have the abovementioned meaning, R**5 represents phenyl, naphthyl or indolyl, the phenyl radical optionally being substituted by 1 or 2 identical or different substituents from the group comprising fluorine, chlorine, nitro, cyano, alkyl with 1 or 2 C atoms, NR**6 , R**7 , NR**6 COR**7 , the group CH2 -CO-NH2 or acetyl and X represents the group COOR**10 , wherein R**10 represents a straight-chain, branched or cyclic alkyl radical which has up to 12 C atoms and is optionally interrupted in the chain by an oxygen atom and/or is optionally substituted by fluorine, chlorine, hydroxyl, pyridyl, phenyl or amino, or represents the group COR**9 , wherein R**9 has the abovementioned meaning, and pharmaceutically acceptable acid addition salts thereof.
FI854171A 1984-10-26 1985-10-24 1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL. FI854171L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66490484A 1984-10-26 1984-10-26
US76918185A 1985-08-23 1985-08-23

Publications (2)

Publication Number Publication Date
FI854171A0 FI854171A0 (en) 1985-10-24
FI854171L true FI854171L (en) 1986-04-27

Family

ID=27099086

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854171A FI854171L (en) 1984-10-26 1985-10-24 1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL.

Country Status (14)

Country Link
EP (1) EP0179386B1 (en)
KR (1) KR860003222A (en)
CN (1) CN85107866A (en)
AT (1) ATE43838T1 (en)
AU (1) AU4909785A (en)
DE (1) DE3570874D1 (en)
DK (1) DK491285A (en)
ES (1) ES8701725A1 (en)
FI (1) FI854171L (en)
GR (1) GR852569B (en)
HU (1) HU194543B (en)
IL (1) IL76800A0 (en)
NO (1) NO854021L (en)
PT (1) PT81366B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60156671A (en) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd Dihydropyridine derivative and its preparation
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
JPS6112662A (en) * 1984-06-28 1986-01-21 Yamanouchi Pharmaceut Co Ltd Dihydropyridine derivative and its production
EP0254682A1 (en) * 1986-07-22 1988-01-27 Ciba-Geigy Ag Phenoxyaliphatylphenylenoxyalkylesters and -amides
EP0336132A1 (en) * 1988-03-11 1989-10-11 Byk Gulden Lomberg Chemische Fabrik GmbH 1-Phenylpropyl compounds
DE3833893A1 (en) * 1988-10-05 1990-04-12 Bayer Ag USE OF BASIC NITRO-PHENYL-DIHYDROPYRIDINE AMIDES AS A MEDICINAL PRODUCT, NEW COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF NEW INTERMEDIATE PRODUCTS
DE3833894A1 (en) * 1988-10-05 1990-04-12 Bayer Ag BASIC DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS INTERMEDIATE PRODUCTS
GB9102031D0 (en) * 1991-01-30 1991-03-13 Fujisawa Pharmaceutical Co Dihydropyridine compounds,and process for their preparation
JPH08502038A (en) * 1992-07-28 1996-03-05 藤沢薬品工業株式会社 1,4-Dihydropyridine derivative having antihypertensive effect and method for producing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2753946A1 (en) * 1977-12-03 1979-06-13 Bayer Ag 1-N-ARYL-1,4-DIHYDROPYRIDINE AND THEIR USE AS A MEDICINAL PRODUCT
DE3208628A1 (en) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
JPS60156671A (en) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd Dihydropyridine derivative and its preparation
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties

Also Published As

Publication number Publication date
ES8701725A1 (en) 1986-12-01
HU194543B (en) 1988-02-29
EP0179386B1 (en) 1989-06-07
EP0179386A2 (en) 1986-04-30
NO854021L (en) 1986-04-28
CN85107866A (en) 1986-07-30
HUT40080A (en) 1986-11-28
DK491285D0 (en) 1985-10-25
DK491285A (en) 1986-04-27
ATE43838T1 (en) 1989-06-15
DE3570874D1 (en) 1989-07-13
EP0179386A3 (en) 1987-08-05
ES548187A0 (en) 1986-12-01
PT81366A (en) 1985-11-01
KR860003222A (en) 1986-05-21
IL76800A0 (en) 1986-02-28
AU4909785A (en) 1986-05-01
PT81366B (en) 1987-08-05
FI854171A0 (en) 1985-10-24
GR852569B (en) 1986-02-25

Similar Documents

Publication Publication Date Title
ATE50987T1 (en) DIHYDROPYRIDE DERIVATIVES, THEIR PREPARATION AND USE.
FI854171L (en) 1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL.
DK452687A (en) DIHYDROPYRIDINE COMPOUNDS, ISOMERS, ISOMER MIXTURES, OPTICAL ANTIPODES AND RACEMATES THEREOF, THEIR PREPARATION AND USE AS MEDICINES
DE68905407D1 (en) ANALGETIC CARBONIC ACID DERIVATIVES.
DK492283A (en) PROCEDURE FOR THE PREPARATION OF NAPHTHALEND DERIVATIVES
ES527739A0 (en) A PROCEDURE FOR PREPARING PIRIMIDINE DERIVATIVES
ATE38675T1 (en) PHOSPHATE ESTER DERIVATIVES AND THEIR USE AS AN ANTI-CANCER AGENT.
DE3650373D1 (en) Morpholine derivatives, processes for their preparation and their use as fungicides.
DK6880A (en) 4-AMINOPRYRIDINES PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DK352081A (en) METHOD FOR PREPARING 3- (N-ARYLAMINO) -TETRAHYDROTHIOPHEN2-ON DERIVATIVES

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT